The Common Technical Document is a harmonized structure for organizing regulatory submission information into modules covering administrative data, quality summaries, nonclinical study reports, and clinical study reports in a standardized sequence. It allows applicants to prepare one core dossier that can be adapted, translated, and localized for submission to multiple regulatory authorities, reducing redundant writing and supporting consistent review across regions.
In translation and localization, CTD/eCTD content appears in marketing authorization applications, lifecycle submissions, deficiency responses, and regulatory correspondence across various regions. Translators work with module-specific terminology, cross-references, heading hierarchy, and eCTD bookmarks, and often rely on translation memory to keep repeated sections such as quality summaries and clinical overviews consistent.
A frequent translation error is altering heading numbering, cross-references, or eCTD bookmark structures, which can break electronic submission validation and delay acceptance. Another common mistake is rendering “summary” and “overview” inconsistently within Module 2, making the relationship between quality and clinical summaries unclear to regulatory reviewers and creating ambiguity during review.
FDA, CE/MDR and NMPA reviewers assess the submitted wording itself. Regulatory bodies require traceable, accountable translation, and an inconsistent term can delay or fail a submission.
Angel Translation locks terms like this into a project terminology base before expert review begins, so the same source term resolves to the same target term across every document in a submission — and stays consistent in the next revision. See the 8-step AI + expert workflow.
Send us the files. Acknowledged in 4 hours, quoted in 24.
Request a Quote →Life Science solutions →